BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 265 filers reported holding BIONTECH SE in Q3 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,787,920 | -11.3% | 25,662 | -11.9% | 1.74% | +33.5% |
| Q2 2023 | $3,142,382 | -17.4% | 29,115 | -4.7% | 1.30% | -42.8% |
| Q1 2023 | $3,805,115 | -15.5% | 30,546 | +1.9% | 2.28% | -25.6% |
| Q4 2022 | $4,504,797 | +8.5% | 29,988 | -2.6% | 3.06% | -15.2% |
| Q3 2022 | $4,153,000 | -35.1% | 30,788 | -28.3% | 3.61% | -5.3% |
| Q2 2022 | $6,404,000 | +161.8% | 42,953 | +199.5% | 3.81% | +335.2% |
| Q1 2022 | $2,446,000 | -71.0% | 14,340 | -56.2% | 0.88% | -67.7% |
| Q4 2021 | $8,444,000 | -39.2% | 32,754 | -35.6% | 2.71% | -32.3% |
| Q3 2021 | $13,887,000 | -9.1% | 50,870 | -25.4% | 4.00% | +8.2% |
| Q2 2021 | $15,270,000 | +128.7% | 68,206 | +11.5% | 3.70% | +101.9% |
| Q1 2021 | $6,678,000 | +66.5% | 61,163 | +24.3% | 1.83% | +56.4% |
| Q4 2020 | $4,012,000 | – | 49,210 | – | 1.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 148,674 | $16,151,943 | 19.26% |
| Quinn Opportunity Partners LLC | 659,383 | $71,635,369 | 9.22% |
| Systrade AG | 50,000 | $5,432,000 | 4.70% |
| Crocodile Capital Partners GmbH | 29,586 | $3,214,223 | 3.03% |
| ALTRINSIC GLOBAL ADVISORS LLC | 700,421 | $76,093,737 | 2.94% |
| Temasek Holdings (Private) Ltd | 4,518,080 | $490,844,211 | 2.92% |
| PARUS FINANCE (UK) Ltd | 25,662 | $2,787,920 | 1.74% |
| FLOSSBACH VON STORCH AG | 3,513,215 | $381,675,678 | 1.68% |
| AtonRa Partners | 4,707 | $511,368 | 1.07% |
| Baader Bank Aktiengesellschaft | 135,093 | $14,617,456 | 0.99% |